Skip to Main Content

COVID-19

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.cdc.gov/coronavirus/

Get the latest research information from NIH: https://covid19.nih.gov/

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Association Between Prevalent Screen-Detected Colorectal Adenoma and Colorectal Cancer Family History Joel Weissfeld University of Pittsburgh PLCO Jul 1, 2006 2006-0262
Adherence to Repeat Screening Flexible Sigmoidoscopy in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Robert Schoen University of Pittsburgh PLCO Jul 1, 2006 2006-0263
Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results from the Baseline Screening Examination. Joel Weissfeld University of Pittsburgh PLCO Jul 1, 2006 2006-0264
Prostate Cancer Dietary Factors - Dietary Patterns Jiyoung Ahn NCI, DCEG, NEB PLCO Jul 1, 2006 2006-0266
Collection of Detailed Ethnicity to Enable Ethnicity-Specific Analyses of PLCO Data Lance Yokochi PHREI PLCO Jul 1, 2006 2006-0268
Using the SF-36 to Track Health Status Outcomes Among Participants in the PLCO Lance Yokochi PHREI PLCO Jul 1, 2006 2006-0270
Colorectal Adenoma -Dietary Factors Carotenoids Regina Ziegler NCI, DCEG, EBP PLCO Jul 1, 2006 2006-0273
Colorectal Adenoma -One-Carbon Metabolism, Biochemical and Genetic Regina Ziegler NCI, DCEG, EBP PLCO Jul 1, 2006 2006-0275
Colorectal Adenoma and Tocopherols, Carotenoids Regina Ziegler NCI, DCEG, EBP PLCO Jul 1, 2006 2006-0276
Racial Factors and Compliance with PLCO Procedures Joel Weissfeld University of Pittsburgh PLCO Jul 1, 2006 2006-0278
HSQ Validation Study Lisa Gren University of Utah PLCO Jul 1, 2006 2006-0310
Effects of Distance and Screening Type on Compliance Sheryl Ogden University of Colorado Health Sciences Center PLCO Jul 1, 2006 2006-0311
Recruitment of Minorities in the PLCO Trial Paul Pinsky NCI, DCP, EDRG PLCO Jul 1, 2006 2006-0312
Diagnostic Procedures Following Lung Cancer Screens with non-Cancer Abnormalities Lois Lamerato Henry Ford Health System PLCO Jul 1, 2006 2006-0315
Questionnaire Risk Factors and Multiple Disease Outcomes in PLCO Wen-Yi Huang NCI, DCEG, OEEB PLCO Jul 1, 2006 2006-0321
Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma Ola Landgren NCI, DCEG, GEB PLCO Jun 7, 2006 2005-0017
Functional DNA Repair Assays for Lung Cancer Risk: Prospective Analysis Alice Sigurdson NCI PLCO May 17, 2006 2005-0013
Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Apr 21, 2006 2005-0014
Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk Demetrius Albanes Extramural PLCO Apr 21, 2006 2005-0018
Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0021